North Brunswick, NJ, United States of America

Mary Jo Donovan


Average Co-Inventor Count = 8.6

ph-index = 2

Forward Citations = 116(Granted Patents)


Company Filing History:


Years Active: 2000-2004

Loading Chart...
3 patents (USPTO):

Title: Mary Jo Donovan: Innovator in Stereoselective Processes

Introduction

Mary Jo Donovan, based in North Brunswick, NJ, is a distinguished inventor recognized for her significant contributions to the field of stereoselective processes. With a total of three patents to her name, her work primarily focuses on advancements that can aid in treating serious conditions such as Alzheimer’s disease.

Latest Patents

Among her latest innovations, two patents stand out. The first, titled "Stereoselective Reduction of Substituted Acetophenone," involves novel stereoselective processes for preparing (S)-1-arylethanols through the reduction of keto group containing compounds using microorganisms. The resulting (S)-1-arylethanols are vital intermediates in synthesizing compounds that inhibit γ-secretase, which has therapeutic implications for Alzheimer's disease.

The second patent, "Stereoselective Reductive Amination of Ketones," describes processes for the enzymatic conversion of certain keto carboxylic acid derivatives to form corresponding alkylamino acid compounds. This invention includes engineered yeast host cells that express specific recombinant nucleic acids capable of producing phenylalanine dehydrogenase and formate dehydrogenase enzymes, further enhancing the applications in biochemical synthesis.

Career Highlights

Mary Jo Donovan serves as an innovator at Bristol-Myers Squibb Company, a leading global biopharmaceutical firm. Her expertise has led to her recognition as a key figure in her field, focusing on the intersection of biotechnology and pharmaceutical development.

Collaborations

Throughout her career, Mary Jo has collaborated with esteemed coworkers Ramesh N. Patel and Steven L. Goldberg. Their combined expertise has contributed to the success of her innovative projects and the effective realization of cutting-edge research initiatives.

Conclusion

Mary Jo Donovan exemplifies the spirit of innovation and dedication in the biotech industry. Her contributions, particularly in the development of stereoselective processes, not only advance scientific understanding but also pave the way for potential new treatments for serious diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…